Elevated levels of the gut hormone GLP-1 and its receptor may worsen brain inflammation and trigger severe symptoms in patients with neuromyelitis optica spectrum disorder (NMOSD), suggesting GLP-1 ...

Findings from an international database seem encouraging but could be due to confounders or older GLP-1 receptor agonists.

Medical experts discuss whether GLP-1 medications, including Mounjaro and Zepbound, could become comprehensive treatments for ...

Delayed gastric emptying, potential aspiration risks, and medication interactions — learn the hospitalist’s approach to ...

GLP-1 drugs have been in the news a lot lately. Most recently, Serena Williams went public about taking GLP-1s as part of her weight loss journey. In a nutshell, GLP-1s are a trending topic—and one ...

Lots of research suggests such medications must be used indefinitely to maintain weight loss and related health benefits. But ...

Patients with rheumatoid arthritis (RA) who used GLP-1 receptor agonists had less disease activity and improved ...

A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for ...

GLP-1 receptor agonists may reduce the likelihood of mortality and increase odds for transplant wait-listing for patients ...

Columnist Teri Sforza writes that studies have found that the popular weight-loss and diabetes drugs reduced alcohol intake, binge drinking and relapse.

The Bravo TV kingpin has opened up on his experience with the wildly popular Ozempic-like drugs that many have turned to for ...

Novo Nordisk reported results from its phase 3 clinical trial for its experimental obesity drug cagrilintide which showed significant weight loss among participants. The research, presented at the ...